Analyst Ratings For Charles River Laboratories International (NYSE:CRL)
Today, Barclays PLC reiterated its Hold rating on Charles River Laboratories International (NYSE:CRL) with a price target of $102.00.
There are 4 hold ratings, 3 buy ratings on the stock.
The current consensus rating on Charles River Laboratories International (NYSE:CRL) is Hold (Score: 2.43) with a consensus target price of $96.93 per share, a potential 3.20% downside.
Some recent analyst ratings include
- 7/19/2017-Barclays PLC Reiterated Rating of Hold.
- 6/30/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 6/28/2017-Citigroup Inc. Reiterated Rating of Neutral.
- 6/6/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 1/4/2017-Evercore ISI Upgrade from a “Hold ” rating to a ” Buy” rating.
- 12/16/2016-Goldman Sachs Group, Inc. (The) Upgrade from a “Sell ” rating to a ” Neutral” rating.
Recent Insider Trading Activity For Charles River Laboratories International (NYSE:CRL)
Charles River Laboratories International (NYSE:CRL) has insider ownership of 2.20% and institutional ownership of 97.61%.
- On 7/17/2017 George Massaro, Director, sold 3,830 with an average share price of $100.81 per share and the total transaction amounting to $386,102.30. View SEC Filing
- On 7/10/2017 James C Foster, Chairman, sold 9,516 with an average share price of $98.92 per share and the total transaction amounting to $941,322.72. View SEC Filing
- On 6/22/2017 Davide Molho, Insider, sold 10,948 with an average share price of $100.00 per share and the total transaction amounting to $1,094,800.00. View SEC Filing
- On 6/22/2017 James C Foster, Chairman, sold 43,154 with an average share price of $100.00 per share and the total transaction amounting to $4,315,400.00. View SEC Filing
- On 6/8/2017 David Ross Smith, Insider, sold 945 with an average share price of $95.00 per share and the total transaction amounting to $89,775.00. View SEC Filing
- On 5/26/2017 Davide Molho, Insider, sold 10,976 with an average share price of $92.84 per share and the total transaction amounting to $1,019,011.84. View SEC Filing
- On 5/12/2017 George Massaro, Director, sold 1,130 with an average share price of $88.30 per share and the total transaction amounting to $99,779.00. View SEC Filing
Recent Trading Activity for Charles River Laboratories International (NYSE:CRL)
Shares of Charles River Laboratories International closed the previous trading session at 100.13 up +0.44 0.44% with 220,500 shares trading hands.